Working... Menu

Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's A Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02303756
Recruitment Status : Completed
First Posted : December 1, 2014
Last Update Posted : June 7, 2018
Information provided by (Responsible Party):
Niels Qvist, Odense University Hospital

Brief Summary:
The primary aim is to evaluate the efficiency of capsule endoscopy (CCE) in in the detection of neoplasms compared to conventional colonoscopy in persons participating in the Danish screening program for colorectal cancer with a positive fecal occult blood with the colonoscopy being the gold standard.

Condition or disease Intervention/treatment Phase
Rectal Bleeding Device: Pillcam® COLON Capsule Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 250 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's
Study Start Date : August 2015
Actual Primary Completion Date : July 2016
Actual Study Completion Date : August 2016

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Pillcam® COLON Capsule
Detection of neoplastic lesions in colon and rectum compared to colonoscopy
Device: Pillcam® COLON Capsule

Primary Outcome Measures :
  1. Identification of neoplasia [ Time Frame: One week after examination ]
    Compared to colonoscopy

Secondary Outcome Measures :
  1. Completion rate [ Time Frame: 24 hours ]
    Documented capsule excretion on the viedorecordin

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Positive feaecal occult bleeding test at screening

Exclusion Criteria:

  • Previous gastrointestinal surgery except for appendectomy
  • Known inflammatory bowel disease including Chrohn's disease and ulcerative colitis
  • An ostomy
  • Symptoms on bowel obstruction (recurrent abdominal pain, constipation or vomiting within the last 3 months)
  • Vomiting in connection with the bowel emptying procedure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02303756

Layout table for location information
Odesne University Hospital
Odense, Denmark, 5000
Sponsors and Collaborators
Odense University Hospital
Layout table for investigator information
Principal Investigator: Niels Qvist, professor Odense University Hospital